Evidence map›Paper›PMID 35398352›Full record

ArticleThe Journal of biological chemistry2022

Ribosomal protein S18 acetyltransferase RimI is responsible for the acetylation of elongation factor Tu.

Philipp I Pletnev, Olga Shulenina, Sergey Evfratov, Vsevolod Treshin, Maksim F Subach, Marina V Serebryakova, Ilya A Osterman, Alena Paleskava, Alexey A Bogdanov, Olga A Dontsova and 2 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. NProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Whole genome sequencing distinguishes skin colonizing from infection-associatedFrontiers in cellular and infection microbiology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Biomolecules · 2023
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Philipp I PletnevDepartment of Chemistry, Lomonosov Moscow State University, Moscow, Russia; Department of Functioning of Living Systems, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.
Olga ShuleninaPetersburg Nuclear Physics Institute, NRC Kurchatov Institute, Gatchina, Russia; NRC Kurchatov Institute, Moscow, Russia.
Sergey EvfratovDepartment of Chemistry, Lomonosov Moscow State University, Moscow, Russia.
Vsevolod TreshinDepartment of Chemistry, Lomonosov Moscow State University, Moscow, Russia.
Maksim F SubachDepartment of Chemistry, Lomonosov Moscow State University, Moscow, Russia.
Marina V SerebryakovaCenter of Life Sciences, Skolkovo Institute for Science and Technology, Moscow, Russia; Department of RNA Structure and Functions, A.N. Belozersky Institute of Physico-Chemical Biology, Moscow, Russia.
Ilya A OstermanDepartment of Chemistry, Lomonosov Moscow State University, Moscow, Russia; Center of Life Sciences, Skolkovo Institute for Science and Technology, Moscow, Russia.
Alena PaleskavaPetersburg Nuclear Physics Institute, NRC Kurchatov Institute, Gatchina, Russia; Institute of Biomedical Systems and Biotechnologies, Peter the Great St. Petersburg Polytechnic University, Saint Petersburg, Russia.
Alexey A BogdanovDepartment of Chemistry, Lomonosov Moscow State University, Moscow, Russia; Department of RNA Structure and Functions, A.N. Belozersky Institute of Physico-Chemical Biology, Moscow, Russia.
Olga A DontsovaDepartment of Chemistry, Lomonosov Moscow State University, Moscow, Russia; Department of Functioning of Living Systems, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia; Center of Life Sciences, Skolkovo Institute for Science and Technology, Moscow, Russia; Department of RNA Structure and Functions, A.N. Belozersky Institute of Physico-Chemical Biology, Moscow, Russia.
Andrey L KonevegaPetersburg Nuclear Physics Institute, NRC Kurchatov Institute, Gatchina, Russia; NRC Kurchatov Institute, Moscow, Russia; Institute of Biomedical Systems and Biotechnologies, Peter the Great St. Petersburg Polytechnic University, Saint Petersburg, Russia. Electronic address: konevega_al@pnpi.nrcki.ru.
Petr V SergievDepartment of Chemistry, Lomonosov Moscow State University, Moscow, Russia; Center of Life Sciences, Skolkovo Institute for Science and Technology, Moscow, Russia; Department of RNA Structure and Functions, A.N. Belozersky Institute of Physico-Chemical Biology, Moscow, Russia; Institute of Functional Genomics, Lomonosov Moscow State University, Moscow, Russia. Electronic address: petya@genebee.msu.ru.
Lomonosov Moscow State University · RUSkolkovo Institute of Science and Technology · RUPeter the Great St. Petersburg Polytechnic University · RUKurchatov Institute · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

N-terminal acetylation is widespread in the eukaryotic proteome but in bacteria is restricted to a small number of proteins mainly involved in translation. It was long known that elongation factor Tu (EF-Tu) is N-terminally acetylated, whereas the enzyme responsible for this process was unclear. Here, we report that RimI acetyltransferase, known to modify ribosomal protein S18, is likewise responsible for N-acetylation of the EF-Tu. With the help of inducible tufA expression plasmid, we demonstrated that the acetylation does not alter the stability of EF-Tu. Binding of aminoacyl tRNA to the recombinant EF-Tu in vitro was found to be unaffected by the acetylation. At the same time, with the help of fast kinetics methods, we demonstrate that an acetylated variant of EF-Tu more efficiently accelerates A-site occupation by aminoacyl-tRNA, thus increasing the efficiency of in vitro translation. Finally, we show that a strain devoid of RimI has a reduced growth rate, expanded to an evolutionary timescale, and might potentially promote conservation of the acetylation mechanism of S18 and EF-Tu. This study increased our understanding of the modification of bacterial translation apparatus.

Indexed as

AcetyltransferasesPeptide Elongation Factor TuAcetylationBacteriaGuanosine TriphosphateKineticsPeptide Elongation FactorsRibosomal ProteinsRibosomesRNA, Transfer, Amino AcylAcetyltransferasesGuanosine TriphosphatePeptide Elongation FactorsPeptide Elongation Factor TuRibosomal Proteinsribosomal protein S18RNA, Transfer, Amino AcylbacteriaEF-Tupost-translational modificationribosome

Identifiers

PMID35398352
PMCPMC9079301
OpenAlexW4223600320

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.